Clincosm LogoSign in Get a demo

pharmacokinetic

Showing 1 - 25 of 30
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pharmacokinetic Trial in Changchun (Lanifibranor)

Active, not recruiting
  • Pharmacokinetic
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Nov 13, 2023

Healthy, Pharmacokinetic Trial in Bangkok (Regimen 1 (Oral primaquine), Regimen 2 (IV primaquine phosphate), Regimen 3 (IV

Not yet recruiting
  • Healthy
  • Pharmacokinetic
  • Regimen 1 (Oral primaquine)
  • +2 more
  • Bangkok, Thailand
    Faculty of Tropical Medicine, Mahidol University
Jul 5, 2023

Pharmacokinetic, Healthy, Drug Combination Trial in Bangkok (Artemether-lumefantrine, Amodiaquine, Artemether-lumefantrine +

Recruiting
  • Pharmacokinetic
  • +2 more
  • Bangkok, Thailand
    Faculty of Tropical Medicine, Mahidol University
Nov 11, 2022

Tolerance, Pharmacokinetic Trial in Wuhan (F573, Placebo)

Completed
  • Tolerance
  • Pharmacokinetic
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Nov 7, 2022

Antibiotics in Intensive Care Patients:Cohort Study PopTDM-ICU

Not yet recruiting
  • Intensive Care Unit
  • +2 more
    • (no location specified)
    Aug 3, 2022

    Citrate Toxicity, Regional Citrate Anticoagulation, Liver Failure, Acute Trial in Bangkok (Pharmacokinetic study)

    Completed
    • Citrate Toxicity
    • +5 more
    • Pharmacokinetic study
    • Bangkok, Thailand
      Chulalongkorn university
    Mar 31, 2022

    Safety Issues, Pharmacokinetic Trial in Kiel (controlled-ileocolonic-release nicotinamide (SAD/MAD/MD), Immediate-release

    Recruiting
    • Safety Issues
    • Pharmacokinetic
    • controlled-ileocolonic-release nicotinamide (SAD/MAD/MD)
    • +3 more
    • Kiel, Germany
      University Medical Center Schleswig-Holstein
    Feb 16, 2022

    Abiraterone Acetate, Gene Polymorphism, Pharmacokinetic Trial in Wuhan (Abiraterone acetate tablets)

    Active, not recruiting
    • Abiraterone Acetate
    • +4 more
    • Abiraterone acetate tablets
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Dec 30, 2021

    Pharmacokinetic Trial in Zurich (Nalbuphine)

    Terminated
    • Pharmacokinetic
    • Zurich, Switzerland
      Childens Hospital Zurich
    Dec 13, 2021

    Pharmacokinetic Trial in Ruddington (PLENVU powder for oral solution)

    Completed
    Has Results
    • Pharmacokinetic
    • PLENVU powder for oral solution
    • Ruddington, Nottingham, United Kingdom
      Quotient Sciences (Quotient),
    Oct 5, 2021

    Pharmacokinetic Trial in Uppsala (Formulation A GS-248, Formulation B GS-248)

    Completed
    Has Results
    • Pharmacokinetic
    • Formulation A GS-248
    • Formulation B GS-248
    • Uppsala, Sweden
      Clinical Trial Consultants AB
    Aug 4, 2021

    Prolonged QTc Interval, Pharmacokinetic Trial in West Bend (100 µg cebranopadol, 200 µg cebranopadol, 400 µg cebranopadol)

    Completed
    • Prolonged QTc Interval
    • Pharmacokinetic
    • 100 μg cebranopadol
    • +5 more
    • West Bend, Wisconsin
      US001 Contract research organization
    Jul 13, 2021

    Pharmacokinetic Trial in Miami, Orlando (Cebranopadol 200 µg tablet)

    Completed
    • Pharmacokinetic
    • Cebranopadol 200 μg tablet
    • Miami, Florida
    • +1 more
    Jul 13, 2021

    Pharmacokinetic Trial in Montreal (INV-101, Placebo)

    Completed
    • Pharmacokinetic
    • Montreal, Quebec, Canada
      Altasciences
    Jun 10, 2021

    Pharmacokinetic, Tolerability, Safety Trial in Warngau (AP701)

    Completed
    • Pharmacokinetic
    • +2 more
    • Warngau, Bavaria, Germany
      Phase I Unit of CannaXan GmbH
    Mar 9, 2021

    Pleural Infection, Empyema, Community-acquired Pneumonia Trial in Amiens (procedure, biological, drug)

    Unknown status
    • Pleural Infection
    • +4 more
    • chest tube drainage
    • +2 more
    • Amiens, France
      CHU Amiens
    Apr 16, 2020

    Pharmacokinetic Trial (SHR-1314)

    Unknown status
    • Pharmacokinetic
    • (no location specified)
    Mar 26, 2020

    Pharmacokinetic Trial (rifaximin)

    Completed
    • Pharmacokinetic
    • (no location specified)
    Nov 26, 2019

    Transplantation, Kidney, Pharmacokinetic Trial in France (Tacrolimus monohydrate (ADOPORT®))

    Completed
    • Transplantation
    • +2 more
    • Tacrolimus monohydrate (ADOPORT®)
    • Amiens, France
    • +4 more
    Sep 5, 2019

    Pharmacokinetic, Drug Combination, Healthy Trial in Bangkok (Artemether-lumefantrine, Amodiaquine, Artemether-lumefantrine +

    Terminated
    • Pharmacokinetic
    • +2 more
    • Bangkok, Thailand
      Faculty of Tropical Medicine, Mahidol University
    Jun 27, 2019

    Pharmacokinetic Trial in Merksem (Tapentadol IR capsule, Omeprazole capsule)

    Completed
    • Pharmacokinetic
    • Tapentadol IR capsule
    • Omeprazole capsule
    • Merksem, Belgium
      J&JPRD Clinical Pharmacology Unit
    Jun 6, 2019

    Prolonged QTc Interval, Pharmacokinetic Trial in Neuss (100 mg CG5503 (tapentadol HCl) PR tablet, Placebo matching CG5503 PR

    Completed
    • Prolonged QTc Interval
    • Pharmacokinetic
    • 100 mg CG5503 (tapentadol hydrochloride) PR tablet
    • +3 more
    • Neuss, Germany
      DE001 - Contract research organisation
    May 15, 2019

    Pharmacokinetic Trial in Aachen (4 ml CG5503, 5 g charcoal powder)

    Completed
    • Pharmacokinetic
    • 4 ml CG5503
    • 5 g charcoal powder
    • Aachen, Germany
      Department of Clinical Pharmacology Grünenthal GmbH
    May 14, 2019

    Sepsis, Septic Shock, Critical Illness Trial in Ratchathewi (Meropenem standard dose, Meropenem high dose)

    Completed
    • Sepsis
    • +8 more
    • Meropenem standard dose
    • Meropenem high dose
    • Ratchathewi, Bangkok, Thailand
      Faculty of Medicine Ramathibodi Hospital
    Mar 9, 2019

    Pharmacokinetic Trial in Changsha (TQ-A3326, )

    Unknown status
    • Pharmacokinetic
    • Changsha, Hunan, China
      The Third Hospital of Changsha
    Dec 9, 2018